At a glance
ClinicalIndex Comparison RecordN/ACompleted· 159 enrolled
Drug / intervention
Data collectionsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cardiorespiratory Fitness and the Apolipoprotein E (ApoE) Genotype and Its Interaction With Cognitive Functions and Cognitive Decline in Late-Middle-Aged Older Adults: A Prospective Study
In Brief
An observational study evaluating Data collections for Aging and Cognitive Change. Completed, enrolled 159 participants across 1 site.
Detailed Summary
The current research project aims to investigate the interaction of cardiorespiratory fitness (CRF) and the ApoE genotype with neurocognitive functions.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAging, Cognitive Change
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
Primary CompletionApr 2021
Study CompletionMay 2021
First PostedDec 2022
TodayJul 2026
First PostedDec 15, 2022
Enrollment StartJul 1, 2018
Primary CompletionApr 1, 2021
Study CompletionMay 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 3.5 years ago
Interventions
Data collectionsother
Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.